-transparent.png){kind=logo}
The clinical effect of intratumoral administration of OK-432 was evaluated. The patients with nonresectable advanced cancer were divided into three groups according to administration method of OK-432 at laparotomy: Group I; Intratumoral administration, Group II; Scattering to the abdominal cavity, and Group III; No OK-432, administration. Improvement in suppression of tumor progression was more frequently noticed in the Group I compared to the Group II and III, but there was no significant difference in terms of survival time and rate among the three groups.
Related Publications
K Shimada, and
K Tabuse, and
N Kono, and
M Katsumi, and
H Yamamoto, and
Y Yamamoto, and
A Endo
November 1988,
The Japanese journal of surgery,
K Shimada, and
K Tabuse, and
N Kono, and
M Katsumi, and
H Yamamoto, and
Y Yamamoto, and
A Endo
June 1983,
Hiroshima journal of medical sciences,
K Shimada, and
K Tabuse, and
N Kono, and
M Katsumi, and
H Yamamoto, and
Y Yamamoto, and
A Endo
February 1988,
Gan to kagaku ryoho. Cancer & chemotherapy,
K Shimada, and
K Tabuse, and
N Kono, and
M Katsumi, and
H Yamamoto, and
Y Yamamoto, and
A Endo
December 1979,
Nagoya journal of medical science,
K Shimada, and
K Tabuse, and
N Kono, and
M Katsumi, and
H Yamamoto, and
Y Yamamoto, and
A Endo
January 2001,
Anticancer research,
K Shimada, and
K Tabuse, and
N Kono, and
M Katsumi, and
H Yamamoto, and
Y Yamamoto, and
A Endo
February 1976,
Gan,
K Shimada, and
K Tabuse, and
N Kono, and
M Katsumi, and
H Yamamoto, and
Y Yamamoto, and
A Endo
October 2004,
Gan to kagaku ryoho. Cancer & chemotherapy,
K Shimada, and
K Tabuse, and
N Kono, and
M Katsumi, and
H Yamamoto, and
Y Yamamoto, and
A Endo
March 1989,
Gan to kagaku ryoho. Cancer & chemotherapy,
K Shimada, and
K Tabuse, and
N Kono, and
M Katsumi, and
H Yamamoto, and
Y Yamamoto, and
A Endo
March 1986,
Gan to kagaku ryoho. Cancer & chemotherapy,
K Shimada, and
K Tabuse, and
N Kono, and
M Katsumi, and
H Yamamoto, and
Y Yamamoto, and
A Endo
September 1989,
Nihon Geka Gakkai zasshi,
